INSIG Corporation

Based in Canada, INSIG Corporation operates an innovative online healthcare platform that provides virtual appointments and a range of medical services, aiming to enhance patient access to healthcare professionals. INSIG Corporation, founded in 2018 and headquartered in Vancouver, Canada, offers telehealth services focused on improving healthcare accessibility. The company was founded by David Del Balso, who has a history in the healthcare sector. INSIG raised USD 24.

27 mn in Series A funding on May 28, 2020, led by Threshold Ventures, with contributions from ACME Capital and others. This funding is part of their ongoing strategy to enhance their service offerings, with only one recorded deal to date. INSIG Corporation provides a comprehensive suite of online healthcare services designed to modernize and streamline access to medical care. Their core offerings include virtual appointments with a diverse network of healthcare providers, such as family doctors, specialists, nurse practitioners, and psychotherapists.

Users can access services such as obtaining doctor’s notes, prescriptions, lab requisitions, and referrals to specialists from the comfort of their homes, effectively eliminating the need for traditional waiting rooms and in-person visits. The company operates primarily in Ontario, British Columbia, and Alberta, where its services are free for patients possessing valid health cards. Tia Health's target clientele includes individuals seeking immediate healthcare solutions, those requiring follow-up consultations, and patients managing chronic conditions, making their platform widely applicable across various demographics. INSIG Corporation's revenue model includes both free and fee-based services.

While online consultations are free for eligible residents in British Columbia, Alberta, and Ontario with valid health cards, patients from other provinces can access services starting at USD 55 per appointment. The company facilitates transactions directly between healthcare providers and patients, ensuring a seamless experience in obtaining necessary medical documentation and prescriptions. This direct-to-consumer approach allows INSIG to cultivate long-term relationships with its users while promoting effective healthcare delivery. Their flagship services, such as online therapy and prescription renewals, enhance the overall patient experience and drive engagement with the platform.

Following the recent Series A funding round of USD 24. 27 mn closed on May 28, 2020, INSIG Corporation plans to utilize the investment to expand its telehealth and clinical services into new markets. Ms. Carolyn Witte will continue leading the company as CEO.

The company aims to introduce new products and services aimed at improving patient access to healthcare and intends to target additional regions for expansion, although specific markets and timelines have not been disclosed.